Kaya Holdings (KAYS) Net Income towards Common Stockholders Growth (3y) (2014 - 2025)
Kaya Holdings (KAYS) Net Income towards Common Stockholders Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 33.22% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 2.94% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 4.50% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 26.82% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 66.11% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -17.90% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -30.70% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 253.53% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -109.16% |
| 10 | Kaya Holdings | - | - | 5,370.00 | -46.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -46.72% |
| Jun 30, 2025 | -41.22% |
| Mar 31, 2025 | -15.17% |
| Dec 31, 2024 | 56.02% |
| Sep 30, 2024 | -38.06% |
| Jun 30, 2024 | -66.11% |
| Mar 31, 2024 | 41.49% |
| Dec 31, 2023 | -73.91% |
| Sep 30, 2023 | 27.08% |
| Jun 30, 2023 | 34.26% |
| Mar 31, 2023 | 28.10% |
| Dec 31, 2022 | -99.71% |
| Sep 30, 2022 | 108.68% |
| Jun 30, 2022 | -7.38% |
| Mar 31, 2022 | -31.20% |
| Dec 31, 2021 | -22.84% |
| Sep 30, 2021 | 89.59% |
| Jun 30, 2021 | 99.85% |
| Mar 31, 2021 | -34.52% |
| Dec 31, 2020 | 29.97% |